Skip to Content

Digital Evidence Generation: FDA Perspectives on Computer Simulations in the Evaluation of Medical Devices

On-Demand Webinar | 58 minutes

Learn about the FDA’s perspectives on the use of simulation (digital evidence generation) in the development and regulatory evaluation of medical devices.

FDA Perspectives on Modeling and Simulation

FDA acknowledges the benefits to public health provided by modeling and simulation, and routinely advises the medical device industry on the use of simulation methodologies so that safe and effective new therapeutics can advance more efficiently, from design to preclinical studies through clinical trials to market.

In this webinar, FDA’s Dr. Tina Morrison, Deputy Director, Division of Applied Mechanics, Center for Devices and Radiological Health, U.S. Food and Drug Administration, provides an overview of those methodologies and highlights the possibility for in silico clinical trials to be used for evaluating medical products.

Realize LIVE Europe | November 3-4, 2020 | Virtual

Realize LIVE Europe, registration now open

Realize LIVE Europe 2020 -  Register now to join Realize LIVE virtually

Don't miss your opportunity to participate in two days of engaging content, networking, and building those meaningful connections at the NEW Realize LIVE Europe virtual conference.



Enhance your knowledge and proficiency with the tools you have, learn from the thought leadership and customer stories that will help guide your organization's continued digital transformation.